Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taiglididine for Laryngeal Mask Insertion in Elderly Patients
NCT07096115Not yet recruiting
- Sponsor
- First People's Hospital of Lianyungang City
- Start
- Sep 2025
- Primary completion
- Jun 2027
- Modality
- Small Molecules
01
Overview
Open-label trial of taiglididine, sponsored by First People's Hospital of Lianyungang City. Primary endpoint: Number of patients with positive laryngeal mask insertion response. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
taiglididine
Beyond the preview
Go deeper on NCT07096115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07096115.